Copyright: Content may be subjected to copyright.
How to cite:Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
- Wang, T(2021). The QBRC neoantigen calling pipeline. Bio-protocol Preprint. bio-protocol.org/prep1455.
- Lu, T., Wang, S., Xu, L., Zhou, Q., Singla, N., Gao, J., Manna, S., Pop, L., Xie, Z., Chen, M., Luke, J. J., Brugarolas, J., Hannan, R. and Wang, T.(2020). Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes . Science Immunology 5(44). DOI: 10.1126/sciimmunol.aaz3199
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
Post a Question 0 Q&A